Literature DB >> 25111369

Neonatal lung function and therapeutics.

Richard L Auten1, Kathryn N Farrow.   

Abstract

Respiratory diseases are increasingly recognized as having their origins during perinatal and early postnatal lung development, a time of significant adaptation to large changes in redox conditions as well as to mechanical forces. This Forum of the journal presents a Forum highlighting studies of the interplay between reactive oxygen/nitrogen species and the systems that have evolved to degrade them or exploit them, as well as the cellular repair processes which respond to early life redox stress in the lung. This group of authors suggests new understandings of these events that may point the way to improved therapeutic approaches.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25111369      PMCID: PMC4239672          DOI: 10.1089/ars.2014.5959

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  9 in total

Review 1.  The role of genetic polymorphisms in antioxidant enzymes and potential antioxidant therapies in neonatal lung disease.

Authors:  Carlo Dani; Chiara Poggi
Journal:  Antioxid Redox Signal       Date:  2014-02-19       Impact factor: 8.401

Review 2.  MSC microvesicles for the treatment of lung disease: a new paradigm for cell-free therapy.

Authors:  Konstantinos Sdrimas; Stella Kourembanas
Journal:  Antioxid Redox Signal       Date:  2014-02-24       Impact factor: 8.401

Review 3.  Lung mesenchymal stromal cells in development and disease: to serve and protect?

Authors:  Jennifer J P Collins; Bernard Thébaud
Journal:  Antioxid Redox Signal       Date:  2014-03-11       Impact factor: 8.401

Review 4.  Role of reactive oxygen species in neonatal pulmonary vascular disease.

Authors:  Stephen Wedgwood; Robin H Steinhorn
Journal:  Antioxid Redox Signal       Date:  2014-02-19       Impact factor: 8.401

Review 5.  The lung alveolar lipofibroblast: an evolutionary strategy against neonatal hyperoxic lung injury.

Authors:  Virender K Rehan; John S Torday
Journal:  Antioxid Redox Signal       Date:  2014-03-12       Impact factor: 8.401

Review 6.  Heme oxygenase in neonatal lung injury and repair.

Authors:  Phyllis A Dennery
Journal:  Antioxid Redox Signal       Date:  2014-02-19       Impact factor: 8.401

Review 7.  The thioredoxin system in neonatal lung disease.

Authors:  Trent E Tipple
Journal:  Antioxid Redox Signal       Date:  2014-03-13       Impact factor: 8.401

Review 8.  Developmental regulation of antioxidant enzymes and their impact on neonatal lung disease.

Authors:  Sara K Berkelhamer; Kathryn N Farrow
Journal:  Antioxid Redox Signal       Date:  2014-02-06       Impact factor: 8.401

9.  Hyperoxia inhibits nitric oxide treatment effects in alveolar epithelial cells via effects on L-type amino acid transporter-1.

Authors:  Mulugu V Brahmajothi; Brian T Tinch; Michael F Wempe; Hitoshi Endou; Richard L Auten
Journal:  Antioxid Redox Signal       Date:  2014-09-22       Impact factor: 8.401

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.